Human Ect2 and methods of use

Details for Australian Patent Application No. 2002211665 (hide)

Owner Exelixis, Inc.

Inventors Keegan, Kevin Patrick; Matthews, David; Joly, Alison; Stout, Thomas J.; Ollmann, Michael Martin

Agent Davies Collison Cave

Pub. Number AU-B-2002211665

PCT Pub. Number WO02/30963

Priority 60239689 12.10.00 US

Filing date 12 October 2001

Wipo publication date 22 April 2002

Acceptance publication date 20 October 2005

International Classifications

C07K 014/00 Peptides having more than 20 amino acids

C12P 021/06 Preparation of peptides or proteins - produced by the hydrolysis of a peptide bond, e.g. hydrolysate products

G01N 033/53 Investigating or analysing materials by specific methods not covered by groups - Immunoassay

Event Publications

20 October 2005 Application Accepted

  Published as AU-B-2002211665

16 February 2006 Standard Patent Sealed

7 May 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002211666-Sulfide and disulfide compounds and compositions for cholesterol management and related uses

2002211664-TWIST-LOCK CONNECTOR FOR ELECTRICAL PLUG AND WALL SOCKET